April 29 (Reuters) - Labopharm Inc:
* Labopharm and Angelini to establish joint venture to commercialize
Oleptro in the United States
* Says joint venture, Angelini Labopharm, will be 50 percent owned by each of
Labopharm and Angelini
* Angelini Labopharm will have exclusive right to market and sell Oleptro in
the United States .
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Labopharm and Angelini to establish joint venture to commercialize
Oleptro in the United States
* Says joint venture, Angelini Labopharm, will be 50 percent owned by each of
Labopharm and Angelini
* Angelini Labopharm will have exclusive right to market and sell Oleptro in
the United States .
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.